Shares of R1 RCM RCM fell 4.5% in pre-market trading after the company reported Q1 results.
Earnings per share fell 4840.00% year over year to ($2.37), which may not compare to the estimate of ($0.03).
Revenue of $342,600,000 higher by 6.90% from the same period last year, which beat the estimate of $339,190,000.
R1 RCM hasn't issued any earnings guidance for the time being.
R1 RCM hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: May 04, 2021
Time: 08:00 AM
ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.r1rcm.com%2F&eventid=3079676&sessionid=1&key=BF783075067206D197962D6C29D2BF84®Tag=&V2=false&sourcepage=register
52-week high: $31.28
52-week low: $8.34
Price action over last quarter: down 11.07%
R1 RCM Inc helps U.S. hospitals, physicians and other healthcare providers to more efficiently manage their revenue cycle operations, which encompass patient registration, insurance, and benefits verification, medical treatment documentation and coding, bill preparation and collections. The company's core offering consists of comprehensive, integrated technology and revenue cycle management services. The majority of the revenue comes from the operating fees received.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.